Effects of micronized fenofibrate on insulin resistance in patients with metabolic syndrome.
about
Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a reviewFenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemiaK-111: the emerging evidence for its potential in the treatment of the metabolic syndrome.Plasma triglycerides are not related to tissue lipids and insulin sensitivity in elderly following PPAR-alpha agonist treatment.Comparative risk of severe hypoglycemia among concomitant users of thiazolidinedione antidiabetic agents and antihyperlipidemicsFenofibrate administration to arthritic rats increases adiponectin and leptin and prevents oxidative muscle wasting.
P2860
Effects of micronized fenofibrate on insulin resistance in patients with metabolic syndrome.
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Effects of micronized fenofibr ...... ients with metabolic syndrome.
@ast
Effects of micronized fenofibr ...... ients with metabolic syndrome.
@en
Effects of micronized fenofibr ...... ients with metabolic syndrome.
@nl
type
label
Effects of micronized fenofibr ...... ients with metabolic syndrome.
@ast
Effects of micronized fenofibr ...... ients with metabolic syndrome.
@en
Effects of micronized fenofibr ...... ients with metabolic syndrome.
@nl
prefLabel
Effects of micronized fenofibr ...... ients with metabolic syndrome.
@ast
Effects of micronized fenofibr ...... ients with metabolic syndrome.
@en
Effects of micronized fenofibr ...... ients with metabolic syndrome.
@nl
P2093
P1476
Effects of micronized fenofibr ...... ients with metabolic syndrome.
@en
P2093
P304
P577
2004-04-01T00:00:00Z